Protein in St. Johns Wort Found to Suppress HIV-1 Gene Expression


A novel protein, p27SJ, extracted from a callus culture of the St. Johns wort plant (Hypericum perforatum) suppresses HIV-1 expression and inhibits its replication, according to researchers at Temple University School of Medicines department of neuroscience and Center for Neurovirology (CNV).

Their findings, p27SJ, a novel protein in St. Johns wort, that suppresses expression of HIV-1 genome, will be published online in the Oct. 27 issue of Gene Therapy. Kamel Khalili, PhD, director of CNV, professor, and acting chair of Temples department of neuroscience, and the studys lead author, said the researchers were originally examining plant extracts from St. Johns wort cultured in the laboratory to see if they had any effect on cell growth or the behavior of brain cells in vitro.

During the course of that study, we also looked to see whether these plant extracts that we had isolated from the callus culture had any anti-viral activity, said Khalili. We soon discovered that the plant extract inhibited HIV-1 gene expression and replication in infected cells.

Next, the team sought to isolate the protein from the plant extract responsible for the observed anti-viral activity. After identifying the protein, the group cloned the gene, which they realized was a novel protein and named p27SJ.

It has unique characteristics, said Khalili. Remember, it is a plant protein, and so far, to my knowledge, there is no similar protein to that in mammalian cells.

After cloning the gene, the researchers then were able to identify the molecular mechanism by which the protein is able to suppress HIV-1 gene expression and replication, according to Khalili.

It is the expression of the viral gene and the replication of the viral genome that leads to the development of AIDS in HIV-infected individuals.

Our studies indicate that p27SJ has the capacity to inhibit expression of the HIV-1 gene by interacting with both cellular proteins and viral proteins, said Khalili. Since HIV-1 gene expression relies heavily on these factors, p27SJ can block viral replication by interfering with the proteins recruited by HIV-1 to increase viral gene expression.

Although St. Johns wort is a popular herb that can be purchased as a dietary supplement over the counter in health food stores, neighborhood pharmacies and supermarkets, the Temple researchers did not use the supplement as a source for St. Johns wort during the study. As a supplement, St Johns wort is often taken as an anti-depressant, although the Food and Drug Administration has not approved it as such, so manufacturers cannot advertise it as a depression treatment nor can doctors prescribe it.

Khalili strongly emphasized that the researchers do not know if the p27SJ protein they discovered is present in the St. Johns wort preparations sold as a dietary supplement, and therefore, those tablets should not be considered as a treatment for patients infected with HIV-1.

We dont know yet how we have to deliver the protein to cells infected with HIV-1, he said. Even if the protein were present in the tablets, we dont know how much might be present and whether the protein would be effective when ingested.

The study, which was partially funded through grants from the National Institutes of Health, was done in collaboration with Yerevan State University in Armenia. Khalilis co-investigators included Nune Darbinian-Sarkissian, Armine Darbinyan, Jessica Otte, Sujatha Radhakrishnan, Bassel E. Sawaya, Alla Arzumanyan, Galina Chipitsyna, Jay Rappaport and Shoreh Amini from Temples CNV, and Yuri Popov, an internationally respected plant biologist from Yerevan State University.

Source Temple University

Related Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology  (Image credit: APIC)
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Related Content